Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention

Zografos Theodoros A.; Katritsis Demosthenes G.

首页> 外文期刊>Current pharmaceutical design >Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention

【24h】

Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention

机译：心房颤动和经皮冠状动脉介入治疗患者抗栓治疗的选择

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: In patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI), dual antiplatelet therapy has been shown to effectively prevent stent thrombosis and other ischemic cardiovascular events. The frequent occurrence of atrial fibrillation (AF) and concomitant CAD in the same individuals, suggests that clinicians will encounter many patients treated with PCI who will require anticoagulant treatment for the prevention of the thromboembolic complications of AF.

机译：背景：在接受经皮冠状动脉介入治疗（PCI）的冠状动脉疾病（CAD）患者中，双重抗血小板治疗已显示可有效预防支架血栓形成和其他缺血性心血管事件。在同一个体中房颤（AF）和伴随的CAD的频繁发生，表明临床医生将遇到许多接受PCI治疗的患者，这些患者需要抗凝治疗以预防AF的血栓栓塞性并发症。

著录项

来源
《Current pharmaceutical design》 |2016年第29期|共6页
作者
Zografos Theodoros A.; Katritsis Demosthenes G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
Atrial fibrillation; percutaneous coronary intervention; antiplatelet thepary;

机译：心房颤动;经皮冠状动脉介入治疗;抗血小板治疗;

相似文献

外文文献
中文文献
专利

1. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention Insights From the AUGUSTUS Trial [J] . Windecker Stephan, Lopes Renato D., Massaro Tyler, Circulation: An Official Journal of the American Heart Association . 2019,第23期

机译：心房颤动和急性冠状动脉综合征患者的抗血栓治疗医学或用经皮冠状动脉介入或接受奥古斯都试验的早期冠状动脉干预洞察力
2. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention [J] . Circulation: An Official Journal of the American Heart Association . 2020,第20期

机译：在急性冠状动脉综合征或经皮冠状动脉介入后，心房颤动患者抗血栓治疗的风险/益处课程
3. Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study [J] . Lukas Andreas Heger, Christoph Bode, Marcus Hortmann, Frontiers in Medicine . 2020,第a期

机译：在稳定冠状动脉疾病中经皮冠状动脉介入后心房颤动患者的双途抗血栓治疗：单一中心，单次运营商，回顾性队列研究
4. Effects of Computerized Guideline-Oriented Clinical Decision Support System on Antithrombotic Therapy in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis [C] . Ryota Sakurai, Kazuhiko Ohe MEDINFO . 2019

机译：面向计算机化指南临床决策支持系统对心房颤动患者抗血栓形成的影响：系统综述与荟萃分析
5. Early Identification and Intervention in Patients with Atrial Fibrillation Using an Implantable Cardiac Monitor to Significantly Improve Guideline-Based Anticoagulation Therapy in an Outpatient Cardiology Clinic [D] . Alvarez, Lisa 2019

机译：使用可植入式心脏监护仪对房颤患者的早期识别和干预，可显着改善门诊心脏病学诊所基于指南的抗凝治疗
6. Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention including compliance with current guidelines—data from the POLish Atrial Fibrillation (POL-AF) Registry [O] . Beata Uziębło-Życzkowska, Paweł Krzesiński, Małgorzata Maciorowska, 2021

机译：心房颤动患者进行经皮冠状动脉介入的患者包括遵守来自波兰心房颤动（POL-AF）登记处的当前指南数据
7. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention [O] . Stephan Windecker, Renato D. Lopes, Tyler Massaro, 2019

机译：心房颤动和急性冠状动脉综合征患者的抗血栓治疗医学或经皮冠状动脉介入或接受选修经皮冠状动脉介入治疗

Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention

摘要

著录项

相似文献

相关主题

期刊订阅